Report Detail
Global (United States, European Union and China) Nanoparticles in Biotechnology and Pharmaceuticals Market Research Report 2019-2025
- RnM3695655 |
- 26 August, 2019 |
- Global |
- 123 Pages |
- QYResearch |
- Other
Nanoparticles are sub-nanosized colloidal structures composed of synthetic or semi-synthetic polymers. These are used in biotechnology and pharmaceutical sectors for studying biological systems for diagnosing diseases and focusing on treatment at the molecular level. The properties of many conventional materials alter when formed from nanoparticles, the reason being nanoparticles have a greater surface area per weight than larger particles, making them more reactive to other molecules
The nanoparticle segment of the nanotechnology has wider application in pharmaceuticals such as in drug delivery and drug discovery, and in biotechnology such as in studying cellular dynamics and stem cell research. Nanotechnology is growing steadily supported by governments and technology firms making high investments in developing nanotechnology.
Sedentary lifestyles and unbalanced diets, supported by the growing rate of urbanization, are consequent in increased widespread prevalence of chronic diseases. Chronic and lifestyle diseases such as cancer, heart diseases, stroke, chronic respiratory diseases, and diabetes. Nanoparticles are utilized to determine the biological alterations of peptide and protein fragments. This diagnosis aids in developing new treatment solutions to treat the growing incidences of chronic diseases. The increasing prevalence of chronic diseases is identified to be one of the key trends having a positive impact on the nanoparticles market in biotechnology and pharmaceutical sectors.
In 2019, the market size of Nanoparticles in Biotechnology and Pharmaceuticals is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Nanoparticles in Biotechnology and Pharmaceuticals.
This report studies the global market size of Nanoparticles in Biotechnology and Pharmaceuticals, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Nanoparticles in Biotechnology and Pharmaceuticals production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Roche
GE Healthcare
Merck
Novartis
AMAG Pharmaceuticals
Amgen
Bausch & Lomb
Biogen
Celgene
Gilead
Ipsen
Leadiant Biosciences
nanoComposix
Pacira Pharmaceuticals
Pfizer
Shire
Market Segment by Product Type
Fullerenes
Liquid Crystals
Liposomes
Nanoshells
Quantum dots
Superparamagnetic nanoparticles
Market Segment by Application
Biotechnology
Pharmaceutical
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Nanoparticles in Biotechnology and Pharmaceuticals status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Nanoparticles in Biotechnology and Pharmaceuticals manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Nanoparticles in Biotechnology and Pharmaceuticals are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Fullerenes
- 1.3.3 Liquid Crystals
- 1.3.4 Liposomes
- 1.3.5 Nanoshells
- 1.3.6 Quantum dots
- 1.3.7 Superparamagnetic nanoparticles
- 1.4 Market Segment by Application
- 1.4.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Share by Application (2019-2025)
- 1.4.2 Biotechnology
- 1.4.3 Pharmaceutical
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Production Value 2014-2025
- 2.1.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Production 2014-2025
- 2.1.3 Global Nanoparticles in Biotechnology and Pharmaceuticals Capacity 2014-2025
- 2.1.4 Global Nanoparticles in Biotechnology and Pharmaceuticals Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Size CAGR of Key Regions
- 2.2.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Capacity by Manufacturers
- 3.1.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Manufacturers (2014-2019)
- 3.2.2 Nanoparticles in Biotechnology and Pharmaceuticals Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
- 3.3 Nanoparticles in Biotechnology and Pharmaceuticals Price by Manufacturers
- 3.4 Key Manufacturers Nanoparticles in Biotechnology and Pharmaceuticals Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Nanoparticles in Biotechnology and Pharmaceuticals Market
- 3.6 Key Manufacturers Nanoparticles in Biotechnology and Pharmaceuticals Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Fullerenes Production and Production Value (2014-2019)
- 4.1.2 Liquid Crystals Production and Production Value (2014-2019)
- 4.1.3 Liposomes Production and Production Value (2014-2019)
- 4.1.4 Nanoshells Production and Production Value (2014-2019)
- 4.1.5 Quantum dots Production and Production Value (2014-2019)
- 4.1.6 Superparamagnetic nanoparticles Production and Production Value (2014-2019)
- 4.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Production Market Share by Type
- 4.3 Global Nanoparticles in Biotechnology and Pharmaceuticals Production Value Market Share by Type
- 4.4 Nanoparticles in Biotechnology and Pharmaceuticals Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Consumption by Application
6 Production by Regions
- 6.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Production (History Data) by Regions 2014-2019
- 6.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Nanoparticles in Biotechnology and Pharmaceuticals Production Growth Rate 2014-2019
- 6.3.2 United States Nanoparticles in Biotechnology and Pharmaceuticals Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Nanoparticles in Biotechnology and Pharmaceuticals Import & Export
- 6.4 European Union
- 6.4.1 European Union Nanoparticles in Biotechnology and Pharmaceuticals Production Growth Rate 2014-2019
- 6.4.2 European Union Nanoparticles in Biotechnology and Pharmaceuticals Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Nanoparticles in Biotechnology and Pharmaceuticals Import & Export
- 6.5 China
- 6.5.1 China Nanoparticles in Biotechnology and Pharmaceuticals Production Growth Rate 2014-2019
- 6.5.2 China Nanoparticles in Biotechnology and Pharmaceuticals Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Nanoparticles in Biotechnology and Pharmaceuticals Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Nanoparticles in Biotechnology and Pharmaceuticals Consumption by Regions
- 7.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Nanoparticles in Biotechnology and Pharmaceuticals Consumption by Type
- 7.2.2 United States Nanoparticles in Biotechnology and Pharmaceuticals Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Nanoparticles in Biotechnology and Pharmaceuticals Consumption by Type
- 7.3.2 European Union Nanoparticles in Biotechnology and Pharmaceuticals Consumption by Application
- 7.4 China
- 7.4.1 China Nanoparticles in Biotechnology and Pharmaceuticals Consumption by Type
- 7.4.2 China Nanoparticles in Biotechnology and Pharmaceuticals Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Nanoparticles in Biotechnology and Pharmaceuticals Consumption by Type
- 7.5.2 Rest of World Nanoparticles in Biotechnology and Pharmaceuticals Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Roche
- 8.1.1 Roche Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Nanoparticles in Biotechnology and Pharmaceuticals
- 8.1.4 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction
- 8.1.5 Roche Recent Development
- 8.2 GE Healthcare
- 8.2.1 GE Healthcare Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Nanoparticles in Biotechnology and Pharmaceuticals
- 8.2.4 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction
- 8.2.5 GE Healthcare Recent Development
- 8.3 Merck
- 8.3.1 Merck Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Nanoparticles in Biotechnology and Pharmaceuticals
- 8.3.4 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction
- 8.3.5 Merck Recent Development
- 8.4 Novartis
- 8.4.1 Novartis Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Nanoparticles in Biotechnology and Pharmaceuticals
- 8.4.4 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction
- 8.4.5 Novartis Recent Development
- 8.5 AMAG Pharmaceuticals
- 8.5.1 AMAG Pharmaceuticals Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Nanoparticles in Biotechnology and Pharmaceuticals
- 8.5.4 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction
- 8.5.5 AMAG Pharmaceuticals Recent Development
- 8.6 Amgen
- 8.6.1 Amgen Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Nanoparticles in Biotechnology and Pharmaceuticals
- 8.6.4 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction
- 8.6.5 Amgen Recent Development
- 8.7 Bausch & Lomb
- 8.7.1 Bausch & Lomb Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Nanoparticles in Biotechnology and Pharmaceuticals
- 8.7.4 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction
- 8.7.5 Bausch & Lomb Recent Development
- 8.8 Biogen
- 8.8.1 Biogen Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Nanoparticles in Biotechnology and Pharmaceuticals
- 8.8.4 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction
- 8.8.5 Biogen Recent Development
- 8.9 Celgene
- 8.9.1 Celgene Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Nanoparticles in Biotechnology and Pharmaceuticals
- 8.9.4 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction
- 8.9.5 Celgene Recent Development
- 8.10 Gilead
- 8.10.1 Gilead Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Nanoparticles in Biotechnology and Pharmaceuticals
- 8.10.4 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction
- 8.10.5 Gilead Recent Development
- 8.11 Ipsen
- 8.12 Leadiant Biosciences
- 8.13 nanoComposix
- 8.14 Pacira Pharmaceuticals
- 8.15 Pfizer
- 8.16 Shire
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Capacity, Production Forecast 2019-2025
- 9.1.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Production Forecast by Type
- 9.7.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Nanoparticles in Biotechnology and Pharmaceuticals Sales Channels
- 10.2.2 Nanoparticles in Biotechnology and Pharmaceuticals Distributors
- 10.3 Nanoparticles in Biotechnology and Pharmaceuticals Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Nanoparticles in Biotechnology and Pharmaceuticals. Industry analysis & Market Report on Nanoparticles in Biotechnology and Pharmaceuticals is a syndicated market report, published as Global (United States, European Union and China) Nanoparticles in Biotechnology and Pharmaceuticals Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Nanoparticles in Biotechnology and Pharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
